New Results
Microcrystalline hydroxyapatite is not inferior to fluorides in clinical caries prevention: a randomized, double-blind, non-inferiority trial
Ulrich Schlagenhauf, Karl-Heinz Kunzelmann, Christian Hannig, Theodor W. May, Helmut Hösl, Mario Gratza, Gabriele Viergutz, Marco Nazet, Sebastian Schamberger, Peter Proff
doi: https://doi.org/10.1101/306423
Ulrich Schlagenhauf
1Department of Conservative Dentistry and Periodontology, University Hospital Wuerzburg, Wuerzburg, Germany
Karl-Heinz Kunzelmann
2Department of Conservative Dentistry and Periodontology, LMU Munich, Munich, Germany
Christian Hannig
3Clinic of Operative and Pediatric Dentistry, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
Theodor W. May
4Society for Biometry and Psychometry, Bielefeld, Germany
Helmut Hösl
5Department of Orthodontics, University Hospital Regensburg, Regensburg, Germany
Mario Gratza
6Department of Orthodontics, University Hospital Wuerzburg, Wuerzburg, Germany
Gabriele Viergutz
3Clinic of Operative and Pediatric Dentistry, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
Marco Nazet
7Department of Orthodontics, LMU Munich, Munich, Germany
Sebastian Schamberger
8Department of Orthodontics, Carolinum, Johann-Wolfgang-Goethe-University Frankfurt, Frankfurt Germany
Peter Proff
5Department of Orthodontics, University Hospital Regensburg, Regensburg, Germany
Article usage
Posted April 27, 2018.
Microcrystalline hydroxyapatite is not inferior to fluorides in clinical caries prevention: a randomized, double-blind, non-inferiority trial
Ulrich Schlagenhauf, Karl-Heinz Kunzelmann, Christian Hannig, Theodor W. May, Helmut Hösl, Mario Gratza, Gabriele Viergutz, Marco Nazet, Sebastian Schamberger, Peter Proff
bioRxiv 306423; doi: https://doi.org/10.1101/306423
Microcrystalline hydroxyapatite is not inferior to fluorides in clinical caries prevention: a randomized, double-blind, non-inferiority trial
Ulrich Schlagenhauf, Karl-Heinz Kunzelmann, Christian Hannig, Theodor W. May, Helmut Hösl, Mario Gratza, Gabriele Viergutz, Marco Nazet, Sebastian Schamberger, Peter Proff
bioRxiv 306423; doi: https://doi.org/10.1101/306423
Subject Area
Subject Areas
- Biochemistry (11740)
- Bioengineering (8750)
- Bioinformatics (29189)
- Biophysics (14967)
- Cancer Biology (12093)
- Cell Biology (17410)
- Clinical Trials (138)
- Developmental Biology (9420)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18301)
- Genetics (12239)
- Genomics (16797)
- Immunology (11865)
- Microbiology (28070)
- Molecular Biology (11583)
- Neuroscience (60953)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4957)
- Plant Biology (10425)
- Synthetic Biology (2884)
- Systems Biology (7338)
- Zoology (1651)